These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9774771)

  • 1. Anti-hyperactivity medication: methylphenidate and amphetamine.
    Seeman P; Madras BK
    Mol Psychiatry; 1998 Sep; 3(5):386-96. PubMed ID: 9774771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis.
    Seeman P; Madras B
    Behav Brain Res; 2002 Mar; 130(1-2):79-83. PubMed ID: 11864721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
    Faraone SV
    Neurosci Biobehav Rev; 2018 Apr; 87():255-270. PubMed ID: 29428394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.
    Swanson J; Baler RD; Volkow ND
    Neuropsychopharmacology; 2011 Jan; 36(1):207-26. PubMed ID: 20881946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating problem children with stimulant drugs.
    Sroufe LA; Stewart MA
    N Engl J Med; 1973 Aug; 289(8):407-13. PubMed ID: 4146358
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).
    Vles JS; Feron FJ; Hendriksen JG; Jolles J; van Kroonenburgh MJ; Weber WE
    Neuropediatrics; 2003 Apr; 34(2):77-80. PubMed ID: 12776228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action.
    Ruskin DN; Bergstrom DA; Shenker A; Freeman LE; Baek D; Walters JR
    Biol Psychiatry; 2001 Feb; 49(4):340-50. PubMed ID: 11239905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
    Gerlach M; Grünblatt E; Lange KW
    Atten Defic Hyperact Disord; 2013 Jun; 5(2):71-81. PubMed ID: 23605387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.
    Samuels JA; Franco K; Wan F; Sorof JM
    Pediatr Nephrol; 2006 Jan; 21(1):92-5. PubMed ID: 16254730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
    Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The science of stimulant abuse.
    Greenhill LL
    Pediatr Ann; 2006 Aug; 35(8):552-6. PubMed ID: 16986449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development.
    Soto PL; Wilcox KM; Zhou Y; Kumar A; Ator NA; Riddle MA; Wong DF; Weed MR
    Neuropsychopharmacology; 2012 Nov; 37(12):2566-79. PubMed ID: 22805599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
    Stevenson RD; Wolraich ML
    Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant medication to treat attention-deficit/hyperactivity disorder.
    Santosh P
    BMJ; 2017 Jul; 358():j2945. PubMed ID: 28710152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.